Veeva Systems Q2 profit beats estimates, CFO Tim Cabral to retire
Veeva Systems Inc. (NYSE: VEEV) reported a 58% jump in earnings for the second quarter of 2020 as higher subscription...
Health Care
Why Arbutus Biopharma stock dipped to 11-year low?
Arbutus Biopharma Corporation (NASDAQ: ABUS) stock plunged to an 11-year low of $1.31 on Monday due to considerable downside risk...
Amgen to take over Celgene’s OTEZLA for $13.4 billion; Bristol-Myers Squibb increases share buyback plan
Bristol-Myers-Squibb (NASDAQ: BMY) announced that Amgen (NASDAQ: AMGN) will acquire Celgene’s (NASDAQ: CELG) Otezla business for $13.4 billion in a...
Earnings preview: Veeva Systems likely to continue the momentum in Q2
Veeva Systems Inc. (NYSE: VEEV) is set to release its second-quarter earnings on Tuesday, August 27 after the market closes....
Immunogen Inc (NASDAQ: IMGN) Q2 2019 Earnings Call Transcript
Immunogen Inc (IMGN) Q2 2019 earnings call dated Aug 02, 2019 Corporate Participants: Courtney O’Konek — Senior Director of Corporate Communications and Investor...
Exelixis surpasses Q2 earnings estimate by 6 cents
Exelixis Inc. (NASDAQ: EXEL) reported second-quarter earnings of 29 cents per share, down 6.4% year-over-year. The bottom line surpassed the...
Vertex Pharmaceuticals Q2 profit jumps 29%, beats estimates
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported a 29% jump in earnings for the second quarter of 2019 helped by strong...
ACADIA Pharmaceuticals Q2 results beat estimates, raises outlook
ACADIA Pharmaceuticals (NASDAQ: ACAD) stock soared 5% in the after-market trading hours as the biopharma firm reported better-than-expected Q2 results....
Amarin’s stock gains on Q2 results beat
Amarin Corporation plc (NASDAQ: AMRN) reported better-than-expected revenue and earnings for the second quarter of 2019, allowing the stock to...
BioTelemetry Q2 earnings exceed estimates on record revenues; stock up 10%
Medical technology company BioTelemetry, Inc. (NASDAQ: BEAT) reported higher earnings and revenues for the June quarter. Earnings topped expectations, while...
Gilead’s Q2 results beat estimates
Gilead Sciences Inc. (NYSE: GILD) beat market estimates for revenue and earnings in the second quarter of 2019. Shares were...
Amgen beats Q2 earnings and revenue estimates
Amgen Inc. (NASDAQ: AMGN) reported second quarter 2019 adjusted EPS of $3.97 on revenue of $5.9 billion. Analysts had predicted...
Pfizer’s stock suffers as Q2 results and Mylan deal fail to impress Wall Street
Pfizer Inc.’s (NYSE: PFE) shares continue to trade in red after the company narrowly missed revenue estimates for the second...
Celgene Q2 profit beats estimates, lifts FY19 guidance
Celgene Corporation (NASDAQ: CELG) reported a 50% jump in earnings for the second quarter of 2019 helped by higher revenue...
Merck rises on oncology strength post Q2 earnings
Shares of pharmaceutical giant Merck (NYSE: MRK) rose 3% before the market hours on Tuesday after the company reported second-quarter...
Eli Lilly Q2 profit beats estimates, lifts FY19 forecast
Eli Lilly and Company (NYSE: LLY) swung to a profit in the second quarter of 2019 from a loss last...
Illumina’s Q2 results beat market estimates
Illumina Inc. (NASDAQ: ILMN) beat analysts’ forecasts for revenue and earnings in the second quarter of 2019. Despite the beat,...
Earnings preview: What to look for when Gilead reports Q2 results
Gilead Sciences Inc. (NYSE: GILD) is scheduled to report second quarter 2019 earnings results on Tuesday, July 30, after market...
Sanofi slips to a loss in Q2 on Eloctate impairment charge
Sanofi (NASDAQ: SNY) slipped to a loss in the second quarter of 2019 from a profit last year, due to...
Earnings preview: A look at key factors affecting Pfizer’s Q2 results
Pfizer Inc. (NYSE: PFE) is scheduled to report second quarter 2019 earnings results on Tuesday, July 30, before market open....
AbbVie tops Q2 views; lifts FY19 earnings outlook
AbbVie’s (NYSE: ABBV) earnings and revenue for the second quarter of 2019 surpassed Wall Street’s estimates. AbbVie reported adjusted EPS...